Poolbeg Pharma (POLB), a biopharmaceutical company, announces that, further to its announcement in July 2022, it has now received the initial results having completed the Lipopolysaccharide human challenge clinical trial
Traders Cafe with Zak Mir: THG, ORPH, ORCP, BOOM, DEV, ASLR, HEMO, QTZ, THR, BHL, CRCL, DEFI, HGEN, RENE, DEST & CCZ
It may be that after today’s announcement that bears of THG (THG) feel that they may be on the wrong side of the price action. The company said CEO Matthew